Beneficial Effects of Low-Grade Mitochondrial Stress on Metabolic Diseases and Aging
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Mitochondria function as platforms for bioenergetics, nutrient metabolism, intracellular signaling, innate immunity regulators, and modulators of stem cell activity. Thus, the decline in mitochondrial functions causes or correlates with diabetes mellitus and many aging-related diseases. Upon stress or damage, the mitochondria elicit a series of adaptive responses to overcome stress and restore their structural integrity and functional homeostasis. These adaptive responses to low-level or transient mitochondrial stress promote health and resilience to upcoming stress. Beneficial effects of low-grade mitochondrial stress, termed mitohorme sis, have been observed in various organisms, including mammals. Accumulated evidence indicates that treatments boosting mi tohormesis have therapeutic potential in various human diseases accompanied by mitochondrial stress. Here, we review multiple cellular signaling pathways and interorgan communication mechanisms through which mitochondrial stress leads to advanta geous outcomes. We also discuss the relevance of mitohormesis in obesity, diabetes, metabolic liver disease, aging, and exercise.
Abstract
Mitochondria function as platforms for bioenergetics, nutrient metabolism, intracellular signaling, innate immunity regulators, and modulators of stem cell activity. Thus, the decline in mitochondrial functions causes or correlates with diabetes mellitus and many aging-related diseases. Upon stress or damage, the mitochondria elicit a series of adaptive responses to overcome stress and restore their structural integrity and functional homeostasis. These adaptive responses to low-level or transient mitochondrial stress promote health and resilience to upcoming stress. Beneficial effects of low-grade mitochondrial stress, termed mitohorme sis, have been observed in various organisms, including mammals. Accumulated evidence indicates that treatments boosting mi tohormesis have therapeutic potential in various human diseases accompanied by mitochondrial stress. Here, we review multiple cellular signaling pathways and interorgan communication mechanisms through which mitochondrial stress leads to advanta geous outcomes. We also discuss the relevance of mitohormesis in obesity, diabetes, metabolic liver disease, aging, and exercise.
참고문헌 (182)
- Osellame LD, "Cellular and molecular mechanisms of mitochondrial function", Best Pract Res Clin Endocrinol Metab, 26, pp.711~723 (2012)
- Keipert S, "Endogenous FGF21-signaling controls paradoxical obesity resistance of UCP1-deficient mice", Nat Commun, 11, pp.624~ (2020)
- Wajner M, "Mitochondrial dysfunction in fatty acid oxidation disorders : insights from human and animal studies", Biosci Rep, 36, pp.e00281~ (2015)
- Wiederkehr A, "Minireview : implication of mitochondria in insulin secretion and action", Endocrinology, 147, pp.2643~2649 (2006)
- Ristow M, "Oxidative metabolism in cancer growth", Curr Opin Clin Nutr Metab Care, 9, pp.339~345 (2006)
- Fukui H, "The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis?", Trends Neurosci, 31, pp.251~256 (2008)
- Tatsuta T, "Quality control of mitochondria : protection against neurodegeneration and ageing", EMBO J, 27, pp.306~314 (2008)
- Bratic A, "The role of mitochondria in aging", J Clin Invest, 123, pp.951~957 (2013)
- Trifunovic A, "Premature ageing in mice expressing defective mitochondrial DNA polymerase", Nature, 429, pp.417~423 (2004)
- Yun J, "Mitohormesis", Cell Metab, 19, pp.757~766 (2014)
- Ristow M, "Mitohormesis : promoting health and lifespan by increased levels of reactive oxygen species(ROS)", Dose Response, 12, pp.288~341 (2014)
- Michaleas SN, "Theophrastus Bombastus Von Hohenheim(Paracelsus)(1493-1541) : the eminent physician and pioneer of toxicology", Toxicol Rep, 8, pp.411~414 (2021)
- Tapia PC, "Sublethal mitochondrial stress with an attendant stoichiometric augmentation of reactive oxygen species may precipitate many of the beneficial alterations in cellular physiology produced by caloric restriction, intermittent fasting, exercise and dietary phytonutrients : "mitohormesis"for health and vitality", Med Hypotheses, 66, pp.832~843 (2006)
- Ristow M, "How increased oxidative stress promotes longevity and metabolic health : the concept of mitochondrial hormesis(mitohormesis)", Exp Gerontol, 45, pp.410~418 (2010)
- Sagan L, "On the origin of mitosing cells", J Theor Biol, 14, pp.255~274 (1967)
- Sharma MR, "Structure of the mammalian mitochondrial ribosome reveals an expanded functional role for its component proteins", Cell, 115, pp.97~108 (2003)
- Epstein CB, "Genome-wide responses to mitochondrial dysfunction", Mol Biol Cell, 12, pp.297~308 (2001)
- Chae S, "A systems approach for decoding mitochondrial retrograde signaling pathways", Sci Signal, 6, pp.rs4~ (2013)
- Jazwinski SM, "The yeast retrograde response as a model of intracellular signaling of mitochondrial dysfunction", Front Physiol, 3, pp.139~ (2012)
- Rothermel BA, "Transactivation by Rtg1p, a basic helix-loop-helix protein that functions in communication between mitochondria and the nucleus in yeast", J Biol Chem, 270, pp.29476~29482 (1995)
- Rothermel BA, "Rtg3p, a basic helixloop-helix", leucine zipper protein that functions in mitochondrial-induced changes in gene expression, contains independent activation domains, 1997, pp.272, 19801~19807
- Arnould T, "Mitochondria retrograde signaling and the UPRmt : where are we in mammals?", Int J Mol Sci, 16, pp.18224~18251 (2015)
- Zhang J, "ROS and ROSmediated cellular signaling", Oxid Med Cell Longev, 2016, pp.4350965~ (2016)
- Schulz TJ, "Glucose restriction extends Caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress", Cell Metab, 6, pp.280~293 (2007)
- Zarse K, "Impaired insulin", IGF1 signaling extends life span by promoting mitochondrial L-proline catabolism to induce a transient ROS signal, 2012, pp.15, 451~465
- Pan Y, "Regulation of yeast chronological life span by TORC1 via adaptive mitochondrial ROS signaling", Cell Metab, 13, pp.668~678 (2011)
- Jin SM, "Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL", J Cell Biol, 191, pp.933~942 (2010)
- da Cunha FM, "Mitochondrial retrograde signaling : triggers, pathways, and outcomes", Oxid Med Cell Longev, 2015, pp.482582~ (2015)
- Dölle C, "NAD and ADP-ribose metabolism in mitochondria", FEBS J, 280, pp.3530~3541 (2013)
- Houtkooper RH, "Exploring the therapeutic space around NAD+", J Cell Biol, 199, pp.205~209 (2012)
- Tang BL, "Sirt1 and the mitochondria", Mol Cells, 39, pp.87~95 (2016)
- Bugga P, "Sirt3 ameliorates mitochondrial dysfunction and oxidative stress through regulating mitochondrial biogenesis and dynamics in cardiomyoblast", Cell Signal, 94, pp.110309~ (2022)
- Ventura-Clapier R, "Transcriptional control of mitochondrial biogenesis : the central role of PGC-1α", Cardiovasc Res, 79, pp.208~217 (2008)
- Gureev AP, "Regulation of mitochondrial biogenesis as a way for active longevity : interaction between the Nrf2 and PGC-1α signaling pathways", Front Genet, 10, pp.435~ (2019)
- Pickles S, "Mitophagy and quality control mechanisms in mitochondrial maintenance", Curr Biol, 28, pp.R170~R185 (2018)
- Yu R, "Regulation of mammalian mitochondrial dynamics : opportunities and challenges", Front Endocrinol(Lausanne), 11, pp.374~ (2020)
- Youle RJ, "Mitochondrial fission, fusion, and stress", Science, 337, pp.1062~1065 (2012)
- Shpilka T, "The mitochondrial UPR : mechanisms, physiological functions and implications in ageing", Nat Rev Mol Cell Biol, 19, pp.109~120 (2018)
- Mottis A, "Mitocellular communication : shaping health and disease", Science, 366, pp.827~832 (2019)
- Qureshi MA, "The mitochondrial unfolded protein response : signaling from the powerhouse", J Biol Chem, 292, pp.13500~13506 (2017)
- Houtkooper RH, "Mitonuclear protein imbalance as a conserved longevity mechanism", Nature, 497, pp.451~457 (2013)
- Suhm T, "Mitochondrial translation efficiency controls cytoplasmic protein homeostasis", Cell Metab, 27, pp.1309~1322 (2018)
- Durieux J, "The cell-non-autonomous nature of electron transport chain-mediated longevity", Cell, 144, pp.79~91 (2011)
- Khan NA, "mTORC1 regulates mitochondrial integrated stress response and mitochondrial myopathy progression", Cell Metab, 26, pp.419~428 (2017)
- Bootcov MR, "MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily", Proc Natl Acad Sci U S A, 94, pp.11514~11519 (1997)
- Chung HK, "Growth differentiation factor 15 is a myomitokine governing systemic energy homeostasis", J Cell Biol, 216, pp.149~165 (2017)
- Johann K, "The role of GDF15 as a myomitokine", Cells, 10, pp.2990~ (2021)
- Ost M, "Muscle-derived GDF15 drives diurnal anorexia and systemic metabolic remodeling during mitochondrial stress", EMBO Rep, 21, pp.e48804~ (2020)
- Mullican SE, "GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates", Nat Med, 23, pp.1150~1157 (2017)
- Liu X, "Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma", PLoS One, 10, pp.e0127518~ (2015)
- Lee ES, "Growth differentiation factor 15 predicts chronic liver disease severity", Gut Liver, 11, pp.276~282 (2017)
- Kim KH, "Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice", Sci Rep, 8, pp.6789~ (2018)
- Chung HK, "GDF15 deficiency exacerbates chronic alcohol-and carbon tetrachloride-induced liver injury", Sci Rep, 7, pp.17238~ (2017)
- Hsiao EC, "Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury", Mol Cell Biol, 20, pp.3742~3751 (2000)
- Knockaert L, "Carbon tetrachloride-mediated lipid peroxidation induces early mitochondrial alterations in mouse liver", Lab Invest, 92, pp.396~410 (2012)
- Hoek JB, "Alcohol and mitochondria : a dysfunctional relationship", Gastroenterology, 122, pp.2049~2063 (2002)
- Mantena SK, "High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo", Biochem J, 417, pp.183~193 (2009)
- Zhang Y, "Cardioprotective effect of growth differentiation factor 15 against isoproterenol-induced cardiomyocyte apoptosis via regulation of the mitochondrial fusion", Cardiol Discov, 2, pp.89~96 (2022)
- Borner T, "GDF15 induces anorexia through nausea and emesis", Cell Metab, 31, pp.351~362 (2020)
- Jung SB, "Reduced oxidative capacity in macrophages results in systemic insulin resistance", Nat Commun, 9, pp.1551~ (2018)
- Choi MJ, "An adipocyte-specific defect in oxidative phosphorylation increases systemic energy expenditure and protects against diet-induced obesity in mouse models", Diabetologia, 63, pp.837~852 (2020)
- Luan HH, "GDF15 is an inflammation-induced central mediator of tissue tolerance", Cell, 178, pp.1231~1244 (2019)
- Wang X, "hNAG-1 increases lifespan by regulating energy metabolism and insulin", IGF-1, Aging(Albany NY), pp.2014, 6[DOI]
- Coskun T, "Fibroblast growth factor 21 corrects obesity in mice", Endocrinology, 149, pp.6018~6027 (2008)
- Xu J, "Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice", Diabetes, 58, pp.250~259 (2009)
- Kharitonenkov A, "The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21", Endocrinology, 148, pp.774~781 (2007)
- Gaich G, "The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes", Cell Metab, 18, pp.333~340 (2013)
- Kilkenny DM, "The FGF21 receptor signaling complex : Klothoβ, FGFR1c, and other regulatory interactions", Vitam Horm, 101, pp.17~58 (2016)
- Inagaki T, "Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21", Cell Metab, 5, pp.415~425 (2007)
- Kim KH, "Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine", Nat Med, 19, pp.83~92 (2013)
- Badman MK, "Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states", Cell Metab, 5, pp.426~437 (2007)
- Zhang X, "Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans", Diabetes, 57, pp.1246~1253 (2008)
- Fisher FM, "FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis", Genes Dev, 26, pp.271~281 (2012)
- Kim KH, "Acute exercise induces FGF21 expression in mice and in healthy humans", PLoS One, 8, pp.e63517~ (2013)
- Tyynismaa H, "Mitochondrial myopathy induces a starvationlike response", Hum Mol Genet, 19, pp.3948~3958 (2010)
- Forsström S, "Fibroblast growth factor 21 drives dynamics of local and systemic stress responses in mitochondrial myopathy with mtDNA deletions", Cell Metab, 30, pp.1040~1054 (2019)
- Pereira RO, "OPA1 deficiency promotes secretion of FGF21from muscle that prevents obesity and insulin resistance", EMBO J, 36, pp.2126~2145 (2017)
- Pereira RO, "OPA1 deletion in brown adipose tissue improves thermoregulation and systemic metabolism via FGF21", Elife, 10, pp.e66519~ (2021)
- Wang L, "Disruption of mitochondrial fission in the liver protects mice from diet-induced obesity and metabolic deterioration", Diabetologia, 58, pp.2371~2380 (2015)
- Fu T, "Mitophagy directs muscle-adipose crosstalk to alleviate dietary obesity", Cell Rep, 23, pp.1357~1372 (2018)
- Fontaine E, "Metformin-induced mitochondrial complex I inhibition : facts, uncertainties, and consequences", Front Endocrinol(Lausanne), 9, pp.753~ (2018)
- Kim KH, "Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation", Biochem Biophys Res Commun, 440, pp.76~81 (2013)
- Suomalainen A, "FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies : a diagnostic study", Lancet Neurol, 10, pp.806~818 (2011)
- Merry TL, "Mitochondrial-derived peptides in energy metabolism", Am J Physiol Endocrinol Metab, 319, pp.E659~E666 (2020)
- Bodzioch M, "Evidence for potential functionality of nuclearly-encoded humanin isoforms", Genomics, 94, pp.247~256 (2009)
- Hashimoto Y, "A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer’s disease genes and Aβ", Proc Natl Acad Sci U S A, 98, pp.6336~6341 (2001)
- Kuliawat R, "Potent humanin analog increases glucose-stimulated insulin secretion through enhanced metabolism in the β cell", FASEB J, 27, pp.4890~4898 (2013)
- Muzumdar RH, "Humanin : a novel central regulator of peripheral insulin action", PLoS One, 4, pp.e6334~ (2009)
- Cobb LJ, "Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers", Aging(Albany NY), 8, pp.796~809 (2016)
- Kim SJ, "Mitochondrial-derived peptide, SHLP2, a novel protective factor in Parkinson’s disease", Innov Aging, 3(Suppl 1), pp.S838~ (2019)
- Lee C, "The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance", Cell Metab, 21, pp.443~454 (2015)
- Kim KH, "The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress", Cell Metab, 28, pp.516~524 (2018)
- Lu H, "MOTS-c peptide regulates adipose homeostasis to prevent ovariectomy-induced metabolic dysfunction", J Mol Med(Berl), 97, pp.473~485 (2019)
- Wei M, "Mitochondrial-derived peptide MOTS-c attenuates vascular calcification and secondary myocardial remodeling via adenosine monophosphate-activated protein kinase signaling pathway", Cardiorenal Med, 10, pp.42~50 (2020)
- Yan Z, "MOTS-c inhibits osteolysis in the mouse calvaria by affecting osteocyte-osteoclast crosstalk and inhibiting inflammation", Pharmacol Res, 147, pp.104381~ (2019)
- Ming W, "Mitochondria related peptide MOTS-c suppresses ovariectomy-induced bone loss via AMPK activation", Biochem Biophys Res Commun, 476, pp.412~419 (2016)
- Yin X, "The intraperitoneal administration of MOTS-c produces antinociceptive and antiinflammatory effects through the activation of AMPK pathway in the mouse formalin test", Eur J Pharmacol, 870, pp.172909~ (2020)
- Kang SG, "Differential roles of GDF15 and FGF21 in systemic metabolic adaptation to the mitochondrial integrated stress response", iScience, 24, pp.102181~ (2021)
- Hong HJ, "Mitoribosome insufficiency in β cells is associated with type 2diabetes-like islet failure", Exp Mol Med, 54, pp.932~945 (2022)
- Nagar H, "CR6-interacting factor 1 deficiency impairs vascular function by inhibiting the Sirt1-endothelial nitric oxide synthase pathway", Antioxid Redox Signal, 27, pp.234~249 (2017)
- Shin J, "Cardiomyocyte specific deletion of Crif1 causes mitochondrial cardiomyopathy in mice", PLoS One, 8, pp.e53577~ (2013)
- Kim YK, "Disruption of CR6-interacting factor-1(CRIF1)in mouse islet beta cells leads to mitochondrial diabetes with progressive beta cell failure", Diabetologia, 58, pp.771~780 (2015)
- Kim S, "CR6 interacting factor 1 deficiency induces premature senescence via SIRT3 inhibition in endothelial cells", Free Radic Biol Med, 150, pp.161~171 (2020)
- Adjeitey CN, "Mitochondrial uncoupling in skeletal muscle by UCP1 augments energy expenditure and glutathione content while mitigating ROS production", Am J Physiol Endocrinol Metab, 305, pp.E405~E415 (2013)
- Keipert S, "UCP1 ectopically expressed in murine muscle displays native function and mitigates mitochondrial superoxide production", Biochim Biophys Acta, 1797, pp.324~330 (2010)
- Klaus S, "Expression of uncoupling protein 1 in skeletal muscle decreases muscle energy efficiency and affects thermoregulation and substrate oxidation", Physiol Genomics, 21, pp.193~200 (2005)
- Berendzen KM, "Neuroendocrine coordination of mitochondrial stress signaling and proteostasis", Cell, 166, pp.1553~1563 (2016)
- Shao LW, "Neuropeptide signals cell non-autonomous mitochondrial unfolded protein response", Cell Res, 26, pp.1182~1196 (2016)
- Zhang Q, "The mitochondrial unfolded protein response is mediated cell-non-autonomously by retromer-dependent Wnt signaling", Cell, 174, pp.870~883 (2018)
- Zhang Q, "The memory of neuronal mitochondrial stress is inherited transgenerationally via elevated mitochondrial DNA levels", Nat Cell Biol, 23, pp.870~880 (2021)
- Waterson MJ, "Neuronal regulation of energy homeostasis : beyond the hypothalamus and feeding", Cell Metab, 22, pp.962~970 (2015)
- Roh E, "Emerging role of the brain in the homeostatic regulation of energy and glucose metabolism", Exp Mol Med, 48, pp.e216~ (2016)
- Diano S, "Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity", Nat Med, 17, pp.1121~1127 (2011)
- Ramírez S, "Mitochondrial dynamics mediated by mitofusin 1 is required for POMC neuron glucose-sensing and insulin release control", Cell Metab, 25, pp.1390~1399 (2017)
- Santoro A, "DRP1 suppresses leptin and glucose sensing of POMC neurons", Cell Metab, 25, pp.647~660 (2017)
- Kang GM, "Mitohormesis in hypothalamic POMC neurons mediates regular exercise-induced high-turnover metabolism", Cell Metab, 33, pp.334~349 (2021)
- Igual Gil C, "Mitochondrial stress-induced GFRAL signaling controls diurnal food intake and anxiety-like behavior", Life Sci Alliance, 5, pp.e202201495~ (2022)
- Landry T, "Central α-klotho suppresses NPY", AgRP neuron activity and regulates metabolism in mice, 2020, pp.69, 1368~1381
- El-Osta A, "Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia", J Exp Med, 205, pp.2409~2417 (2008)
- Lambertucci RH, "Palmitate increases superoxide production through mitochondrial electron transport chain and NADPH oxidase activity in skeletal muscle cells", J Cell Physiol, 216, pp.796~804 (2008)
- Yi HS, "The mitochondrial unfolded protein response and mitohormesis : a perspective on metabolic diseases", J Mol Endocrinol, 61, pp.R91~R105 (2018)
- Jain SS, "High-fat diet-induced mitochondrial biogenesis is regulated by mitochondrial-derived reactive oxygen species activation of CaMKII", Diabetes, 63, pp.1907~1913 (2014)
- Cheng X, "Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes : a role for mitochondria and the nuclear factor-E2-related factor 2-Kelchlike ECH-associated protein 1 defense pathway", Antioxid Redox Signal, 14, pp.469~487 (2011)
- (NRF2)antioxidant system and prevents insulin resistance and obesity induced by a high-fat diet in C57BL, "6J mice", Diabetologia, 54, pp.922~934 (2011)
- Bhaskaran S, "Loss of mitochondrial protease ClpP protects mice from diet-induced obesity and insulin resistance", EMBO Rep, 19, pp.e45009~ (2018)
- Nishikawa T, "Impact of mitochondrial ROS production on diabetic vascular complications", Diabetes Res Clin Pract, 77(Suppl 1), pp.S41~S45 (2007)
- Myung SK, "Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease : systematic review and meta-analysis of randomised controlled trials", BMJ, 346, pp.f10~ (2013)
- Lonn E, "Effects of long-term vitamin E supplementation on cardiovascular events and cancer : a randomized controlled trial", JAMA, 293, pp.1338~1347 (2005)
- Sharma K, "Mitochondrial hormesis and diabetic complications", Diabetes, 64, pp.663~672 (2015)
- Dugan LL, "AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function", J Clin Invest, 123, pp.4888~4899 (2013)
- Eid AA, "AMP-activated protein kinase(AMPK)negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes", J Biol Chem, 285, pp.37503~37512 (2010)
- Lee MJ, "A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy", Am J Physiol Renal Physiol, 292, pp.F617~F627 (2007)
- Roy Chowdhury SK, "Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes", Brain, 135, pp.1751~1766 (2012)
- Yan W, "Impaired mitochondrial biogenesis due to dysfunctional adiponectin-AMPKPGC-1α signaling contributing to increased vulnerability in diabetic heart", Basic Res Cardiol, 108, pp.329~ (2013)
- Zou MH, "Regulation of interplay between autophagy and apoptosis in the diabetic heart : new role of AMPK", Autophagy, 9, pp.624~625 (2013)
- Yu X, "Salvianolic acid A protects the peripheral nerve function in diabetic rats through regulation of the AMPK-PGC1α-Sirt3 axis", Molecules, 17, pp.11216~11228 (2012)
- Kubota S, "Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation", Invest Ophthalmol Vis Sci, 52, pp.9142~9148 (2011)
- Pearson KJ, "Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span", Cell Metab, 8, pp.157~168 (2008)
- Xie Z, "Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26mice", Diabetes, 60, pp.1770~1778 (2011)
- Liu DQ, "Berberine protects against ischemia-reperfusion injury : a review of evidence from animal models and clinical studies", Pharmacol Res, 148, pp.104385~ (2019)
- Zhu X, "The mitohormetic response as part of the cytoprotection mechanism of berberine : berberine induces mitohormesis and mechanisms", Mol Med, 26, pp.10~ (2020)
- Nassir F, "Role of mitochondria in alcoholic liver disease", World J Gastroenterol, 20, pp.2136~2142 (2014)
- Gariani K, "Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice", Hepatology, 63, pp.1190~1204 (2016)
- Cappello F, "Hsp60 chaperonopathies and chaperonotherapy : targets and agents", Expert Opin Ther Targets, 18, pp.185~208 (2014)
- Rakonczay Z Jr, "Ethanol administration generates oxidative stress in the pancreas and liver, but fails to induce heat-shock proteins in rats", J Gastroenterol Hepatol, 18, pp.858~867 (2003)
- Yuan D, "Kupffer cell-derived Tnf triggers cholangiocellular tumorigenesis through JNK due to chronic mitochondrial dysfunction and ROS", Cancer Cell, 31, pp.771~789 (2017)
- Ko KS, "Liver-specific deletion of prohibitin 1 results in spontaneous liver injury, fibrosis, and hepatocellular carcinoma in mice", Hepatology, 52, pp.2096~2108 (2010)
- Fan W, "Prohibitin 1suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells", Hepatology, 65, pp.1249~1266 (2017)
- Lee HJ, "Downregulation of mitochondrial lon protease impairs mitochondrial function and causes hepatic insulin resistance in human liver SK-HEP-1cells", Diabetologia, 54, pp.1437~1446 (2011)
- Zhu S, "FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPKSIRT1pathway", Acta Biochim Biophys Sin(Shanghai), 46, pp.1041~1048 (2014)
- Liu Y, "Fibroblast growth factor 21 deficiency exacerbates chronic alcohol-induced hepatic steatosis and injury", Sci Rep, 6, pp.31026~ (2016)
- Koo BK, "Growth differentiation factor 15 predicts advanced fibrosis in biopsyproven non-alcoholic fatty liver disease", Liver Int, 38, pp.695~705 (2018)
- Kujoth GC, "Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging", Science, 309, pp.481~484 (2005)
- Vincent AE, "Subcellular origin of mitochondrial DNA deletions in human skeletal muscle", Ann Neurol, 84, pp.289~301 (2018)
- Kim ER, "Short term isocaloric ketogenic diet modulates NLRP3 inflammasome via B-hydroxybutyrate and fibroblast growth factor 21", Front Immunol, 13, pp.843520~ (2022)
- Pinti M, "Circulating mitochondrial DNA increases with age and is a familiar trait : implications for"inflamm-aging"", Eur J Immunol, 44, pp.1552~1562 (2014)
- Lima T, "Pleiotropic effects of mitochondria in aging", Nat Aging, 2, pp.199~213 (2022)
- Sorrentino V, "Enhancing mitochondrial proteostasis reduces amyloid-β proteotoxicity", Nature, 552, pp.187~193 (2017)
- Ahmed AS, "Effect of aging on stem cells", World J Exp Med, 7, pp.1~10 (2017)
- Zhang H, "NAD+repletion improves mitochondrial and stem cell function and enhances life span in mice", Science, 352, pp.1436~1443 (2016)
- Chaudhari SN, "Increased mitochondrial fusion allows the survival of older animals in diverse C. elegans longevity pathways", Nat Commun, 8, pp.182~ (2017)
- Song M, "Abrogating mitochondrial dynamics in mouse hearts accelerates mitochondrial senescence", Cell Metab, 26, pp.872~883 (2017)
- Hansen M, "Autophagy as a promoter of longevity : insights from model organisms", Nat Rev Mol Cell Biol, 19, pp.579~593 (2018)
- Fang EF, "Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease", Nat Neurosci, 22, pp.401~412 (2019)
- Fang EF, "NAD+ augmentation restores mitophagy and limits accelerated aging in Werner syndrome", Nat Commun, 10, pp.5284~ (2019)
- Schwarz C, "Safety and tolerability of spermidine supplementation in mice and older adults with subjective cognitive decline", Aging(Albany NY), 10, pp.19~33 (2018)
- Pengam M, "How do exercise training variables stimulate processes related to mitochondrial biogenesis in slow and fast trout muscle fibres?", Exp Physiol, 106, pp.938~957 (2021)
- Russell AP, "Skeletal muscle mitochondria : a major player in exercise, health and disease", Biochim Biophys Acta, 1840, pp.1276~1284 (2014)
- Kim KB, "Effects of exercise on the body composition and lipid profile of individuals with obesity : a systematic review and meta-analysis", J Obes Metab Syndr, 28, pp.278~294 (2019)
- Huertas JR, "Stay fit, stay young : mitochondria in movement : the role of exercise in the new mitochondrial paradigm", Oxid Med Cell Longev, 2019, pp.7058350~ (2019)
- Pruchnic R, "Exercise training increases intramyocellular lipid and oxidative capacity in older adults", Am J Physiol Endocrinol Metab, 287, pp.E857~E862 (2004)
- Yoon TK, "Exercise, mitohormesis, and mitochondrial ORF of the 12S rRNA type-C(MOTS-c)", Diabetes Metab J, 46, pp.402~413 (2022)
- Merry TL, "Mitohormesis in exercise training", Free Radic Biol Med, 98, pp.123~130 (2016)
- Gomez-Cabrera MC, "Decreasing xanthine oxidase-mediated oxidative stress prevents useful cellular adaptations to exercise in rats", J Physiol, 567, pp.113~120 (2005)
- Ristow M, "Antioxidants prevent health-promoting effects of physical exercise in humans", Proc Natl Acad Sci U S A, 106, pp.8665~8670 (2009)
- Laurens C, "Growth and differentiation factor 15 is secreted by skeletal muscle during exercise and promotes lipolysis in humans", JCI Insight, 5, pp.e131870~ (2020)
- Kim KH, "FGF21 as a stress hormone : the roles of FGF21in stress adaptation and the treatment of metabolic diseases", Diabetes Metab J, 38, pp.245~251 (2014)
- Kim KH, "GDF15 as a central mediator for integrated stress response and a promising therapeutic molecule for metabolic disorders and NASH", Biochim Biophys Acta Gen Subj, 1865, pp.129834~ (2021)
- Woodhead JST, "High-intensity interval exercise increases humanin, a mitochondrial encoded peptide, in the plasma and muscle of men", J Appl Physiol(1985), 128, pp.1346~1354 (2020)
- Reynolds JC, "MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis", Nat Commun, 12, pp.470~ (2021)
- von Walden F, "Acute endurance exercise stimulates circulating levels of mitochondrial-derived peptides in humans", J Appl Physiol(1985), 131, pp.1035~1042 (2021)
- Lin YF, "Maintenance and propagation of a deleterious mitochondrial genome by the mitochondrial unfolded protein response", Nature, 533, pp.416~419 (2016)
